Recently, our laboratory began to characterize the mononuclear cells from human umbilical cord blood (HUCB) both in vitro and in vivo. These cryopreserved human cells are available in unlimited quantities and it is believed that they may represent a source of cells with possible therapeutic and practical value. Our previous molecular and immunocytochemical studies on cultured HUCB cells revealed their ability to respond to nerve growth factor (NGF) by increased expression of neural markers typical for nervous systemderived stem cells. In addition, the DNA microarray detected downregulation of several genes associated with development of blood cell lines. To further explore the survival and phenotypic properties of HUCB cells we transplanted them into the developing rat brain, which is known to provide a conducive environment for development of neural phenotypes. Prior to transplantation, HUCB cells were either cultured with DMEM and fetal bovine serum or were exposed to retinoic acid (RA) and nerve growth factor (NGF). Neonatal pups (1 day old) received unilateral injection of cell suspension into the anterior part of subventricular zone. One month after transplantation animals were perfused, their brains cryosectioned, and immunocytochemistry was performed for identification of neural phenotypes. Our results clearly demonstrated that approximately 20% of transplanted HUCB survived (without immunosuppression) within the neonatal brain. Additionally, double-labeling with cell-type-specific markers revealed that some HUCB-derived cells (recognized by anti-human nuclei labeling) were immunopositive for glial fibrillary acidic protein (GFAP) and few donor cells expressed the neuronal marker TuJ1 (class III β-tubulin). These findings suggest that at least some of the transplanted HUCB cells differentiated into cells with distinct glial or neuronal phenotypes after being exposed to instructive signals from the developing brain.
INTRODUCTION
mant genetic programs as a response to instructive environmental signals.
In the last few years there have been numerous re-Proliferation and differentiation of neural stem cells derived either from embryonic or adult central nervous ports showing the plasticity of nonneural cells. In particular, nonhematopoietic progenitor cells in bone marrow, system (CNS) are highly dependent on the interplay between intrinsic and extrinsic factors; these factors drive under specific conditions, were able to differentiate into myogenic progenitors (8), hepatocytes (12), and into uncommitted neural stem cells to differentiate into cells of a specific neural lineage. Under experimental condi-cells bearing neuronal and glial antigens (11, 17, 19, 23) . Moreover, direct transplantation of human marrow stro-tions it may even be possible for neural stem cells to achieve phenotypic features of cells that are outside the mal cells into the rat striatum or ventricle of neonatal mice resulted in engraftment, survival, migration, and neural lineage and cells from outside the brain to express neural markers typical of CNS-derived stem cells. Thus, differentiation into astrocytes (1, 11) . Besides bone marrow, human umbilical cord blood regardless of their developmental origin, stem cells in some tissues may have greater developmental potential has been recognized recently as another source of stem cells, which might be preferable to other available sources. than originally thought and may "wake up" their dor-Cord blood is rich in hematopoietic progenitor cells and is research was accompanied by the Specimen Data Report showing pre-and postprocessing results including vol-considered an efficacious source of stem cells for clinical reconstitution of bone marrow and blood cell lineages in ume, white blood count, viability, CD34+ cells/microliter, and flow cytometry report. A standard mixture of di-children with malignant and nonmalignant diseases after treatment of myeloablative doses of chemotherapy (15). methyl sulfoxide (DMSO) and RPMI media (Mediatech) was used for cryopreservation. For the current study we From a practical point of view, human umbilical cord blood (HUCB) collected from the placental umbilical used the sample (#R 117) containing 7.4 million white blood cells per milliliter, 11.6% granulocytes, and ϳ41 cord stump after delivery and collection is much easier than bone marrow or neural stem cells. Another advan-CD34+ cells per microliter. The viability of the sample was 98.4%. The Investigational Review Board (IRB) of tage of using HUCB is its relative immune immaturity, similar to fetal cells (21); thus, the risk for rejection is the University of South Florida approved the protocol. reduced and long-term immunosuppressive treatment Preparation of Short-Term Cultures of HUCB may not be required. The total content of hematopoietic In order to identify human cells within the neonatal progenitor cells in both sources is very similar, but the rat brain we tested several human-specific antibodies in more primitive progenitor cells with a high proliferative short-term [1-5 days in vitro (DIV)] cultures. Briefly, potential are present at about an eightfold higher frecryopreserved HUCB cells were thawed into Dulbecco's quency in HUCB than in adult bone marrow (14). Immodified Eagle's medium (DMEM, Gibco) with 10% munophenotypically, hematopoietic stem/progenitor are fetal bovine serum (Gibco) and gentamicin (50 µg/ml, characterized by presence of CD34 antigen (7), func-Sigma). Viability was assessed using trypan blue (75%) tioning as a regulator of hematopoietic cell adhesion to and cells were plated on poly-L-lysine-coated (10 µg/ml, stromal cells of the hematopoietic environment (10).
Sigma) eight-well chamber slides at a concentration of Multipotential progenitor cells with characteristics 100,000 cells/cm 2 . For immunocytochemistry, some culsimilar to neural stem cells have been found recently in tures were fixed (4% paraformaldehyde in 0.1 M phoscultured HUCB (3, 20) . After exposure to retinoic acid phate buffer) after 24 h while others were maintained (RA) and nerve growth factor (NGF), these cells exhibfor additional 2-4 days either in the same medium, or ited neural phenotypes (detected by mRNA expression in DMEM/F12 (Gibco) with 0.1% ITS (Sigma) and genand immunocytochemistry, gene chip analysis and Westtamicin. ern blotting) and expressed Musashi-1, β-tubulin III, and GFAP, molecular markers associated with neurons and Preparation of HUCB Cultures for Transplantation glia. In the current study we wanted to determine whether Prior to transplantation cryopreserved HUCB cells HUCB-derived progenitor cells transplanted into the were thawed, centrifuged, resuspended, and plated in subventricular zone (SVZ) of the neonatal rat brain are 75-mm culture flasks either in DMEM supplemented able to survive and intersperse with endogenous SVZwith fetal bovine serum (10%) for 7 days or after 4 days derived progenitors and/or the surrounding regions. This medium was replaced with Neurobasal medium (Gibco environment has been previously shown to provide in-BRL) with all-trans-retinoic acid (RA; 0.5 µM, Sigma) structive signals for stem/progenitor cells derived from and NGF (100 ng/ml, Sigma) for 3 additional days. For the embryonic (9,22) and neonatal (2,11,24) rodent brain transplantation, HUCB cells were detached from dishes as well as for human neuronally committed hNT cells using mild trypsinization (0.05% trypsin/EDTA, Gibco). (26) . Here we also examined whether previously ob-Prior to transplantation, the viability of lifted HUCB served neural phenotypic markers (TuJ1 and GFAP), excells assessed by trypan blue exclusion was 70%. After pressed by cultured HUCB after their exposure to differseveral careful washes, cells were resuspended with Hank's entiation medium containing RA and NGF, would be balanced salt solution and final concentration of cells for expressed upon transplantation into the neurogenic SVZ transplantation was adjusted to 30,000/µl. of the newborn rat.
MATERIALS AND METHODS

Transplantation of HUCB Into the Neonatal Subventricular Zone Cell Source
Cryopreserved samples of the mononuclear fraction Neonatal 1-day-old Sprague-Dawley rats (n = 13) were anesthetized by hypothermia for 5 min on crushed of HUCB (numbered to maintain anonymity of the donor) were obtained from CryoCell International, Inc.
ice (24, 26) . To guarantee the consistent targeting of the SVZa, the anesthetized pup was positioned under the Within 24-36 h after collection, the HUCB samples were processed; the density gradient centrifugation tech-surgical microscope in a contoured styrofoam slat. A midline skin incision was made to expose bregma. Using nique was employed to isolate the mononuclear fraction. The cryopreserved mononuclear fraction provided for a fine forceps, a small hole was created in the skull on the right hemisphere (1 mm right from the midline, 2 sections were coverslipped with 95% glycerol or Vectastain (Vector) and viewed with an Olympus BX-60 mm anterior to bregma). A Hamilton syringe was slowly lowered into the SVZ (2 mm deep to the pial surface) equipped with rhodamine and fluorescein filters, as well as a dual filter to visualize rhodamine and FITC fluores-through the opening in the skull. Two microliters of cell suspension was slowly delivered into the SVZ at a rate cence simultaneously. Colocalization of two immunomarkers on selected slides was further confirmed by of 1 µl per minute for 2-3 min. Out of 13 animals, 9 received DMEM-treated and 4 received RA + NGF-z-stacking analysis of images collected with a Zeiss laser scanning confocal microscope (LSM 510). The LSM treated HUCB cells ( Table 1 ). Following transplantation the surface of the brain was cleaned, the skin reposi-510 is equipped with two lasers: Argon ion with principal excitation lines at 488 and 514 nm and the HeNe tioned and sealed with surgical glue (Nexaband Liquid, Vet Prod Labs). The pups were placed under a heat lamp (helium/neon) laser lines at 543, 594, and 633 nm. The emission filters were set for wavelengths appropriate for for recovery before being placed back in their home cages. Throughout this study care was taken to follow fluorescein (518 nm maximum) and rhodamine (618 nm maximum). The objective was a Zeiss 63× water immer-the USF IACUC guidelines and the "Principles of Laboratory Animal Care." sion lens.
Tissue Processing and Immunocytochemistry Quantitative Analyses of the Grafted Tissue Slides with short-term cultured HUCB cells fixed
Dispersion of Cells From the Implantation Site. To with 4% paraformaldehyde were immunostained overdetermine how far the transplanted HUCB cells moved night with mouse anti-human mitochondria monoclonal away from implantation site we counted the number of antibody (1:30; Chemicon), nuclear matrix antigen sections through the entire graft. In both experimental (NuMA) (1:400; Oncogene), or anti-human nuclei (1:30; groups (first group: HUCB cells treated with DMEM + Chemicon). These antibodies were employed because FBS; second group: HUCB cells treated with DMEM + they recognize the human origin of the HUCB sample FBS followed by RA + NGF) the mediolateral limits of and were primarily used for identification of HUCB the most representative grafts ( Table 1 , rats #3 and #11) cells in the brain. In addition, culture slides were utilized were determined by the presence of fluorescent-labeled to determine the optimal working dilutions before being nuclei of HUCB cells. applied to brain sections. In controls, primary antibody HUCB Cell Survival. The number of surviving was omitted.
HUCB cells was estimated from counts of fluorescent-The next day after fixation the slides with short-term labeled nuclei of HUCB cells in 12 tissue sections cultures were rinsed in 0.1 M PBS and incubated for through the transplant. Only the clearly labeled nuclei 1 h in the secondary antibody. Biotinylated secondary were taken into consideration. The observed counts were antibody (goat anti-mouse) was applied (1 h) on slides extrapolated to the total number of sections through the with short-term cultured HUCB cells that were exposed graft to estimate the number of surviving HUCB cells (1) . to human mitochondrial antibody or NuMA. The slides Quantitative Assessment of Neuronal and Glial Markwere then incubated in an avidin-biotin solution (Vectasers in Grafted HUCB Cells. First, the double-labeled tain, Elite, Vector, CA) for 1 h at room temperature, rinsed sections through the transplants were prescreened on fluin PBS, and developed using diaminobenzidine (Pierce) or orescent Olympus BX 60 microscope. The number of VIP (Vector) chromogens. Human anti-nuclei were visualsingle-labeled (human nuclei-positive) and double-labeled ized with rhodamine-conjugated goat-anti mouse antibody (human nuclei-positive/GFAP-positive and human nu-(1:700; Alexa Fluor 594, Molecular Probes).
clei-positive/TuJ1-positive) cells was counted in three to One month after implantation of HUCB the injected six random fields (at 40×) per section, three sections per pups were anesthetized by chloroform inhalation and treatment. Then the same sections were examined under perfused transcardially with 4% paraformaldehyde in 0.1 the confocal microscope and only those cells clearly M phosphate buffer (pH, 7.4). The brains were sectioned demonstrating colocalization of two markers were counserially in the sagittal plane on a cryostat at 20 µm thickted. The counts were collected and percentages of douness. Thaw-mounted sections were immunocytochemible-labeled cells for representative grafts in each experically stained with a cocktail of mouse monoclonal antimental group were calculated. body against human nuclei (1:30; Chemicon) and either with rabbit polyclonal antibodies against β-tubulin III RESULTS (1:2000; Covance) or glial fibrillary acidic protein (1:500;
The Phenotype of HUCB in Short-Term Culture Dako). The next day the sections were incubated with appropriate secondary antibodies conjugated to either rhoda-
Prior to transplantation, we tested cultured HUCB plated for a short period of time (1-5 DIV) for assess-mine or fluorescein (1:700; Alexa, Molecular Probes). All ment of cellular morphology and detection of three dif-plantation into the SVZ of the neonatal rat brain (Fig.  2 ). Prior to transplantation HUCB were either exposed ferent immunomarkers specific for human or humanderived cells. Observations of living cultures revealed for 7 days to medium containing DMEM and fetal bovine serum only (see Materials and Methods) or were heterogeneous cell types of different sizes and morphology. Small round cells forming clusters were mixed with cultured first with DMEM and serum (for 4 days) replaced by serum-free medium containing RA and NGF. isolated spindle-shaped or flat large cells. This morphological heterogeneity was also observed in the previous To identify the HUCB transplant within the brain 1 month after implantation, we routinely screened every studies (20) . Immunocytochemically, all three markers were expressed by HUCB cells; NuMA was in approxi-sixth cresyl violet-stained section. When we identified mately 95% of all HUCB cells, while both antimitochondrial and antinuclear antigens were found in virtually every cultured cell (Fig. 1) . Thus, for immunocharacterization of transplanted HUCB cells within the neonatal brain we decided to use the antibody against human nuclei. The nuclear localization of the immunostaining allowed for double labeling with cell-type-specific antibody (TuJ1, GFAP) to identify the phenotype of transplanted HUCB cells (25). In our experiment we wanted to determine the distriwere injected into the anterior part (arrow) of the SVZ (yellow). Corpus callosum overlying the SVZ is blue. bution and phenotype of HUCB cells following their im-those sections that contained graft, adjacent serial sec-were detected only in 11 sections through 220 µm of the brain parenchyma. tions were selected for immunocytochemical identification of HUCB. Within the brain, human antinuclei-posi-To examine the cell survival we utilized the same sections as for the distribution analysis, with fluores-tive HUCB cells (indicating the human origin of cells) were found predominantly within the SVZ, but also in cent-labeled human-positive nuclei identifying the transplant. From the 60,000 cells originally injected we found surrounding locations, including cortex and corpus callosum. We usually found them in small clumps, though 12,300 (20.5%) in the DMEM + FBS group and 10,500 (17.5%) in the NGF + RA-treated group. Collectively, occasionally they occurred as single cells. HUCB with different treatments prior to transplantation were found our findings indicate that HUCB cells subjected to different treatments prior to implantation respond differ-in similar brain regions ( Table 1 ). No HUCB cells were identified in contralateral, nontransplanted hemispheres. ently to signals from the brain microenvironment and that the dispersion of HUCB cells within the brain, as In cresyl violet-stained sections implanted HUCB cells (pretreated either with DMEM and fetal bovine se-well as their survival, may be at least partially influenced by the level of their initial predifferentiation. rum or with RA and NGF prior to transplantation) were readily identified by different packing density and distri-
Identification, Distribution, and Survival
The Incidence of Neural-Specific Markers bution within the area of implantation (Fig. 3) . Taking in Transplanted HUCB into consideration the same amount of cells implanted From both experimental groups (first group: HUCB in both groups, the greater dispersion of cells from the cells treated with DMEM + FBS; second group: HUCB implantation site was observed in DMEM and fetal bocells treated with DMEM + FBS followed by RA + vine serum group. In both groups, the transplanted NGF) we selected adjacent sections to those identified HUCB cells were accompanied by yellowish-brownishas containing human antinuclei-positive cells for cellstained acellular masses representing either dead cells type-specific labeling (see Materials and Methods). Ador accumulated aggregates of hemosiderin. In addition, ditionally, only those animals in which HUCB cells immunolabeling for human nuclei allowed us to deterwere found predominantly within the subventricular mine the distance between the two border sagittal seczone and surrounding regions were taken into considertions (in mediolateral direction), still containing grafted ation (Table 1) .
HUCB cells (see Materials and Methods). The DMEM +
Most of the HUCB cells expressing the glial pheno-FBS-treated transplant was identified in 33 consecutive type (human nuclei positive/GFAP positive) were found sagittal sections (20 µm thick), indicating that cells mainly within the cerebral cortex and corpus callosum were dispersed considerably (660 µm) through the medi-( Fig. 4) . Frequently, GFAP-positive HUCB cells with olateral extent of the brain. NGF + RA-treated cells astrocytic-like morphology were observed around blood vessels (Fig. 4B ). Confocal microscopy confirmed the and glia. These findings allowed us to hypothesize that, express two neural markers, TuJ1 and GFAP, as indicated by our previous in vitro studies (20) . We found under specific conditions, progenitor cells originating from the hematopoietic family are able to express mark-that 30% of transplanted HUCB cells survived within the recipient brain, although few of them expressed the ers observed within neural lineages. Taking into consideration that blood-forming cells have origins from the markers of interest. This survival was slightly better than that observed when human bone marrow stromal cells interplay of the three primary germ layers (27) , their potential to acquire the neural phenotypic properties were transplanted into the corpus striatum of adult rats (1) . That study found only 20% survival (72 days post-may be less surprising than previously appreciated.
A recent in vitro study (20) using immunocytochem-transplantation in comparison to 1 month in our study), although the stromal cells revealed migratory behavior istry, RT-PCR, gene chip analysis, and Western blotting demonstrated that HUCB cells exposed to RA and NGF similar to rat astrocytes, and their immunoreactivity for collagen I and fibronectin, typical hematopoetic mark-treatments responded with increased expression of neural-specific markers, including TuJ1 and GFAP. The ers, was significantly decreased following implantation into the brain. number of TuJ1-immunopositive HUCB cells increased from 8.0% in DMEM-treated cultures to 18.7% in RA + There are several important issues regarding the survival data that need to be discussed. The observation of NGF-treated cultures and GFAP positivity from 34.7% to 66.2%. DNA microarray analysis showed enhanced disintegrating nuclear debris immunolabeled with human-specific antibody indicated that not every HUCB expression of selected genes (pleiotrophin, glypican-4, neuronal growth protein 43, bone morphogenetic protein cell was able to survive within this environment. It is possible that some of these cells were partially damaged 1, and others) associated with neural development. Furthermore, downregulation of genes associated with de-at the time of transplantation when they were detached from culture dishes by mild trypsinization. Also, the im-velopment of blood lines (HLA class I locus C heavy chain, macrophage receptor, attractin, α-1 collagen type paired survival of HUCB could be attributed to their level of differentiation in culture. Whether exposure to II, and others) was also apparent. Collectively, these data revealed that exposure to specific extrinsic factors RA + NGF drove them too far into the differentiation process and therefore they were unable to read addi-could alter the phenotypic fate of HUCB towards neural lineages.
tional instructive signals within the brain will need to be addressed in further studies. In addition, a less probable A similar set of experimental conditions for HUCB cells exposed either to DMEM or to the RA + NGF treat-possibility could be that an interspecies immunological response could affect the overall survival of these cells. ments, prior to transplantation, was used in our study, in which we examined whether exposure to developing This risk, however, is considerably reduced in neonatal animals and was not an issue in studies using a human brain parenchyma may promote their survival in the same manner as described for neural stem/progenitor neuronally committed cells (hNT, also called NT2-N neurons) for grafting into the same model (26) . In future cells (9,22,24) and whether these cells would be able to studies, the rejection issue after xenografting may be ad-injection, the brain, heart, lung, kidney, liver, spleen, bone marrow, and muscle were analyzed for the pres-dressed through application of immunosuppressive drugs (9,18) or through transplantation of HUCB cells into im-ence of donor cells using immunocytochemistry and laser confocal microscopy. Some of the donor cells mi-munodeficient animals.
Intravenously administered HUCB cells were re-grated into the brain and expressed neuronal markers NeuN and MAP2 and the astrocytic marker GFAP. Ad-cently utilized to reduce the neurological deficits caused by traumatic brain injuries (16). One month after HUCB ditionally, intravenous HUCB cell administration was utilized to improve neurological functional recovery the occurrence of HUCB-derived cells with neural phenotypes was rather limited, the functional recovery ob-after stroke (6,13). When the transplants were performed 24 h after the stroke, there was significant improvement served after administration of HUCB cells would be more likely attributed to the production of trophic fac-in motor function at both 7 and 14 days posttransplant (5) as well as at later (4 and 8 weeks) time points (13). tors by HUCB than to their phenotypic shift towards neuronal and glial-like fates. Within the recipient brain the HUCB cells survived, migrated into the ischemic brain, and some of them encir-Recently, intravascular delivery of adult mouse bone marrow cells into lethally irradiated adult host yielded cled blood vessels. Immunoreactivity for both astrocytic (GFAP) and neuronal (NeuN and MAP2) markers was cells expressing genes specific for CNS-derived neurons and demonstrated normal physiological responses (4). confirmed by laser scanning confocal microscopy. These studies showed that HUCB cells were able to migrate Marrow-derived cells with neuronal characteristics (NeuN 200-kDa neurofilament and TuJ1) showed activation of into the damaged area of the brain and express neural markers without previous exposure to various factors.
the transcription factor cAMP response element binding protein (CREB), thus indicating that similar signal trans-However, their migration towards the lesioned area of the brain suggests that damaged tissue releases certain duction pathways typical for neurons could be activated in response to extracellular stimuli (e.g., glutamate, neu-chemotactic proteins, which may attract these cells. As 
